Back
Dave, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
54
DAVE
Dave, Inc.
Last Price:
$215.15
Seasonality Move:
68.23%
Sell
31
MNPR
Monopar Therapeutics, Inc.
Last Price:
$69.11
Seasonality Move:
25.93%
Buy
54
Dave, Inc. (DAVE)
is a Buy
Is Dave, Inc. a Buy, Sell or Hold?
-
The current Dave, Inc. [DAVE] share price is $215.25. The Score for DAVE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
DAVE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $65.99. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAVE Stock Price Chart
What is Dave, Inc.'s stock price today?
-
The Dave, Inc. share price today is $215.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAVE is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $65.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.
DAVE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.81 | Sell |
| Relative Strength Index (14 RSI): | 54.85 | Buy |
| Chaikin Money Flow: | 3344 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (192.95 - 209.99) | Buy |
| Bollinger Bands (100): | (194.74 - 230.6) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.42 | Sell |
| Relative Strength Index (14 RSI): | 32.25 | Sell |
| Chaikin Money Flow: | -36886 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
DAVE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 201.22 | Buy |
| 20-day SMA: | 203.71 | Buy |
| 50-day SMA: | 215.53 | Sell |
| 200-day SMA: | 186.35 | Buy |
| 8-day EMA: | 204.05 | Buy |
| 20-day EMA: | 204.94 | Buy |
| 50-day EMA: | 210.07 | Buy |
| 200-day EMA: | 184.46 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.2 | Sell |
| 20-day SMA: | 79.37 | Sell |
| 50-day SMA: | 82.12 | Sell |
| 200-day SMA: | 52.13 | Buy |
| 8-day EMA: | 72.25 | Sell |
| 20-day EMA: | 76.67 | Sell |
| 50-day EMA: | 77.13 | Sell |
| 200-day EMA: | 56.56 | Buy |
Dave, Inc. Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.18 per share, and an increase next year of $0.09 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Dave, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||